slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 19,891-19,920
Pages 1,437
Rows per page 30
Arc
19,891-19,920 of 43,093
19
The slide presents a downward revision in revenue and EBITDA guidance alongside updated operational assumptions.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · SolutionLoop · Why Now1 hit
20
Bausch Health Companies | Results Presentation Deck | 50 slidesBausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
Bausch Health Companies | Results Presentation Deck | 50 slidesBausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
22
The slide uses a 2x2 grid layout to categorize strategic priorities by business unit.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
23
The slide uses a circular diagram to represent organizational values/pillars surrounding the company name.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
03
The slide uses a linked-circle diagram to represent the company's core value propositions.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide uses a 2x5 grid layout to display 10 team members.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Team1 hit
05
The slide uses a comparative visual framework to contrast healthy cells (no binding) with cancer cells (CAB binding).BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
09
Uses a comparative framework to highlight unmet medical needs in two specific cancer indications.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market Sizing1 hit
17
The chart is a waterfall plot showing maximum change from baseline for different patient cohorts.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
18
The slide uses a process-oriented layout to describe clinical trial phases.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
19
Clinical trial data for BA3011 in NSCLC patients.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
20
Clinical trial data presentation for oncology drug candidate.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
21
The slide serves as a section divider for a deep dive into a specific therapeutic platform.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
22
The slide uses a grid of metrics to define the total addressable market and the specific target segment.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
23
The chart is a waterfall plot showing percentage change in tumor size for individual patients.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
24
The slide uses a 2x2 grid of metrics to frame the market problem, followed by specific target population and success threshold data.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
25
The chart displays longitudinal data for two specific patients, showing sustained complete response.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
26
SCCHN = Squamous Cell Carcinoma of the Head and Neck. ROR2 is the target biomarker.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
27
The slide uses a table to present clinical outcomes for specific tumor types, emphasizing the first-in-class potential of the therapy.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
06
BioNTech | Investor Presentation Deck | 28 slidesBioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProblemLoop · Golden Circle1 hit
07
The slide uses a semi-circular layout to represent the company's strategic pillars.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProblemLoop · Golden Circle1 hit
13
BioNTech | Investor Presentation Deck | 28 slidesBioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
The diagram uses a hexagonal grid to represent different technology platforms and their development status/origin.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
16
Uses a temporal progression layout (Today -> Mid-term -> Long-term).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
17
Includes product image and key performance metrics.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
18
Slide highlights both historical traction (>3.6bn doses) and future growth vectors (label expansion, boosters, next-gen vaccines).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
19
The slide uses a two-column layout to contrast the 'why' (medical need) with the 'how' (technologies).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
20
The chart uses a horizontal bar representation to indicate the clinical stage of each program.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
21
The diagram illustrates a circular, iterative process (flywheel) connecting patient samples and variability to specific drug classes.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit